Fund Overview of Bandhan Healthcare Fund Regular - Idcw
-
₹9.40NAV
-
EquityFund Category
Returns of Bandhan Healthcare Fund Regular - Idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -3.93% | NA | 6.12% |
Asset Allocation
equities
98.06%debt instruments
0.01%other assets or cash equivalents
1.93%Bandhan Healthcare Fund Regular - Idcw is one Equity mutual fund offered by Bandhan Mutual Fund. Launched on 28 Nov 2025, the fund aims To create wealth over a long term. Investment predominantly in equity and equity related instruments of pharma, healthcare and allied companies. The portfolio allocation consists of 98.06% in equities, 0.01% in debt instruments, 1.93% in other assets or cash equivalents.it has delivered a return of 0.00% in the last year, a total return since inception of -6.03%.About Bandhan Healthcare Fund Regular - Idcw
To take better investment decisions it is useful to review best sip plan suited to long-term goals.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -1.83% | -6.17% | 7.88% | 27.92% | 17.69% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -1.90% | -6.36% | 6.99% | 26.83% | 16.66% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.62% | -0.09% | 10.23% | 25.28% | 15.52% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.72% | -0.42% | 8.78% | 23.61% | 13.91% |
More funds from Bandhan Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Bandhan Bse Healthcare Index Fund Regular-growth
|
₹19 | -1.61% | -3.40% | -5.89% | 6.98% | - |
|
Bandhan Bse Healthcare Index Fund Direct-growth
|
₹19 | -1.55% | -3.21% | -5.52% | 7.84% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹37.22 | 26.83% | 16.66% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹40.32 | 27.92% | 17.69% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹33.78 | 25.28% | 15.52% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.50 | 23.61% | 13.91% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹147.53 | 24.92% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹17.44 | 24.04% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹17.09 | 23.26% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹14.79 | 25.08% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Reverse Repo | Unspecified | 41.62% | ₹121.36 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.05% | ₹29.31 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.84% | ₹26.06 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 8.76% | ₹25.81 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.68% | ₹25.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.56% | ₹23.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.82% | ₹23.24 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 8.22% | ₹22.97 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.50% | ₹22.11 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.55% | ₹22.01 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.39% | ₹21.79 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.31% | ₹21.73 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.12% | ₹21.16 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.36% | ₹20.57 Cr |
| Cipla Ltd | Healthcare | 6.86% | ₹20.22 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.77% | ₹19.94 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.93% | ₹19.38 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.42% | ₹19.07 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.48% | ₹18.88 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.75% | ₹18.88 Cr |
| Cipla Ltd | Healthcare | 6.31% | ₹18.74 Cr |
| Cipla Ltd | Healthcare | 6.30% | ₹18.38 Cr |
| Reverse Repo | Unspecified | 6.07% | ₹18.04 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.18% | ₹18.02 Cr |
| Cipla Ltd | Healthcare | 6.01% | ₹16.81 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.57% | ₹16.43 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.55% | ₹16.19 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 5.35% | ₹14.96 Cr |
| Reverse Repo | Unspecified | 5.32% | ₹14.86 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.90% | ₹14.56 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.25% | ₹12.40 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.84% | ₹11.42 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.95% | ₹11.04 Cr |
| Lupin Ltd | Healthcare | 3.51% | ₹10.36 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.43% | ₹10.11 Cr |
| Lupin Ltd | Healthcare | 3.46% | ₹9.69 Cr |
| Lupin Ltd | Healthcare | 3.19% | ₹9.49 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.23% | ₹9.04 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.03% | ₹9.00 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.05% | ₹8.98 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.89% | ₹8.60 Cr |
| Syngene International Ltd | Healthcare | 2.85% | ₹8.46 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.85% | ₹8.32 Cr |
| Global Health Ltd | Healthcare | 2.79% | ₹8.30 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.92% | ₹8.18 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.76% | ₹8.12 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.76% | ₹8.12 Cr |
| Syngene International Ltd | Healthcare | 2.78% | ₹8.10 Cr |
| Global Health Ltd | Healthcare | 2.70% | ₹7.97 Cr |
| Global Health Ltd | Healthcare | 2.64% | ₹7.38 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.48% | ₹7.32 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.59% | ₹7.25 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.39% | ₹7.10 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.38% | ₹6.65 Cr |
| Reverse Repo | Unspecified | 2.21% | ₹6.50 Cr |
| Syngene International Ltd | Healthcare | 2.20% | ₹6.15 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.05% | ₹6.11 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.03% | ₹5.99 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.02% | ₹5.96 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.00% | ₹5.94 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.00% | ₹5.84 Cr |
| Abbott India Ltd | Healthcare | 1.98% | ₹5.84 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.92% | ₹5.66 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.94% | ₹5.66 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.93% | ₹5.63 Cr |
| Syngene International Ltd | Healthcare | 1.86% | ₹5.49 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.83% | ₹5.45 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.85% | ₹5.41 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.82% | ₹5.35 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.83% | ₹5.34 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.82% | ₹5.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.89% | ₹5.28 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.76% | ₹5.14 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.83% | ₹5.12 Cr |
| Pfizer Ltd | Healthcare | 1.72% | ₹5.06 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.79% | ₹5.01 Cr |
| Pfizer Ltd | Healthcare | 1.68% | ₹4.99 Cr |
| Pfizer Ltd | Healthcare | 1.71% | ₹4.98 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.66% | ₹4.95 Cr |
| Abbott India Ltd | Healthcare | 1.66% | ₹4.93 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.73% | ₹4.83 Cr |
| Abbott India Ltd | Healthcare | 1.68% | ₹4.69 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.54% | ₹4.56 Cr |
| Pfizer Ltd | Healthcare | 1.63% | ₹4.56 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.43% | ₹4.21 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.41% | ₹4.11 Cr |
| Sanofi India Ltd | Healthcare | 1.38% | ₹4.09 Cr |
| Sanofi India Ltd | Healthcare | 1.44% | ₹4.02 Cr |
| Sanofi India Ltd | Healthcare | 1.35% | ₹3.97 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.33% | ₹3.93 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.34% | ₹3.75 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.26% | ₹3.72 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.25% | ₹3.70 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.24% | ₹3.69 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.26% | ₹3.68 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.24% | ₹3.68 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.22% | ₹3.64 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.22% | ₹3.62 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.29% | ₹3.61 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.14% | ₹3.37 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.14% | ₹3.33 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.18% | ₹3.31 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.08% | ₹3.22 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.14% | ₹3.19 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.05% | ₹3.06 Cr |
| Abbott India Ltd | Healthcare | 1.03% | ₹3.01 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.01% | ₹2.97 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.05% | ₹2.95 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.92% | ₹2.74 Cr |
| Concord Biotech Ltd. | Healthcare | 0.91% | ₹2.69 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 0.96% | ₹2.69 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.89% | ₹2.64 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.88% | ₹2.60 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.88% | ₹2.45 Cr |
| Concord Biotech Ltd. | Healthcare | 0.83% | ₹2.44 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 0.81% | ₹2.39 Cr |
| Concord Biotech Ltd. | Healthcare | 0.84% | ₹2.35 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.82% | ₹2.29 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.63% | ₹1.86 Cr |
| Orchid Pharma Ltd | Healthcare | 0.61% | ₹1.82 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.60% | ₹1.74 Cr |
| Orchid Pharma Ltd | Healthcare | 0.60% | ₹1.68 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.54% | ₹1.59 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.52% | ₹1.53 Cr |
| Orchid Pharma Ltd | Healthcare | 0.50% | ₹1.49 Cr |
| Concord Biotech Ltd. | Healthcare | 0.49% | ₹1.42 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.45% | ₹1.25 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.41% | ₹1.22 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 0.28% | ₹0.78 Cr |
| Others Mrgn Money | Unspecified | 0.24% | ₹0.69 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 0.23% | ₹0.69 Cr |
| Others Mrgn Money | Unspecified | 0.04% | ₹0.11 Cr |
| Others Mrgn Money | Unspecified | 0.03% | ₹0.09 Cr |
| Others Mrgn Money | Unspecified | 0.01% | ₹0.04 Cr |
| Net Payables | Unspecified | -0.28% | ₹-0.89 Cr |
| Net Payables | Unspecified | -0.57% | ₹-1.70 Cr |
| Net Payables | Unspecified | -0.72% | ₹-2.05 Cr |
| Net Payables | Unspecified | -15.67% | ₹-45.71 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹40.32 | 27.92% | 17.69% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹37.22 | 26.83% | 16.66% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹33.78 | 25.28% | 15.52% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.50 | 23.61% | 13.91% | - |
Frequently Asked Questions
Bandhan Healthcare Fund Regular - Idcw
What is the portfolio composition of Bandhan Healthcare Fund Regular - Idcw?
Equity: 98.06%, Debt: 0.01%, Others: 1.93%.
What is the market-cap allocation of Bandhan Healthcare Fund Regular - Idcw?
Large Cap: 47.03%, Mid Cap: 19.68%, Small Cap: 33.29%.
Which are the top companies Bandhan Healthcare Fund Regular - Idcw has invested in?
- Reverse Repo – 41.62% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.05% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.84% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 8.76% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.68% of the fund's portfolio
Which are the major sectors Bandhan Healthcare Fund Regular - Idcw focuses on?
- Healthcare – 353.98% of the fund's portfolio
- Unspecified – 38.30% of the fund's portfolio
- Industrials – 3.90% of the fund's portfolio
- Financial – 3.82% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





